5 Results for "

integrin α9β1

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "integrin α9β1" in MCE Product Catalog:

Cat. No.: HY-N2587
CAS No.: 548-76-5
Irigenin is a is a lead compound, and mediates its anti-metastatic effect by specifically and selectively blocking α9β1 and α4β1 integrins binding sites on C-C loop of Extra Domain A (EDA). Irigenin shows anti-cancer properties. It sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells .
loading...
    loading...
Cat. No.: HY-129453
CAS No.: 1947348-42-6
Purity:  99.11%
Target:  

Integrin

Research Areas:  

Inflammation/Immunology

BOP sodium is a potent and selective dual α9β1/α4β1 integrin inhibitor with Kd values in the picomolar range. BOP sodium shows the rapid and preferential mobilization of hematopoietic stem cell (HSC) and progenitors. BOP sodium has little inhibitory activity on α4β7, α1β1, α2β1, and α5β1, αIIBβ3 integrins .
loading...
    loading...
Cat. No.: HY-136214
Target:  

Integrin

Research Areas:  

Inflammation/Immunology Cancer

R-BC154 acetate is a selective fluorescent α9β1 integrin antagonist. R-BC154 acetate acts as a useful high affinity, activation dependent integrin probe, which can be used to investigate α9β1 and α4β1 integrin binding activity .
loading...
    loading...
Cat. No.: HY-N2587R
CAS No.: 548-76-5
Irigenin (Standard) is the analytical standard of Irigenin. This product is intended for research and analytical applications. Irigenin is a is a lead compound, and mediates its anti-metastatic effect by specifically and selectively blocking α9β1 and α4β1 integrins binding sites on C-C loop of Extra Domain A (EDA). Irigenin shows anti-cancer properties. It sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells .
loading...
    loading...
Cat. No.: HY-P11648
CAS No.: 292851-89-9
Target:  

Osteopontin

Research Areas:  

Inflammation/Immunology Cancer

SVVYGLR is an osteopontin-derived peptide. SVVYGLR can promote the differentiation of fibroblasts into myofibroblast-like cells and promote the production of type III collagen by cardiac fibroblasts. SVVYGLR can activate the adhesion, migration and tubule formation of endothelial cells in vitro. SVVYGLR promotes angiogenesis and wound healing and promotes the migration of dermal fibroblasts and keratinocytes. SVVYGLR can be used for research related to angiogenesis, dermal wounds and bone regeneration .
loading...
    loading...